ASCO 2023

What’s On-Board

The American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment. ASCO is a multi-day event typically featuring hundreds of presentations, panel discussions, and poster sessions. These sessions cover various topics, from basic science research to clinical trials and patient care.

The DelveInsight team will have a fantastic networking opportunity to expand their networks with industrial individuals all over the world. Our professionals will have the opportunity to attend informative seminars, oncology workshops, and noteworthy educational sessions on themes of particular relevance and interest to clinical oncologists and researchers.

DelveInsight will acknowledge thousands of scientific abstracts being presented at the ASCO Congress based on the most recent updates and findings from cancer clinical trials, including revolutionizing new therapeutic research and changing the perspective of cancer patient care.

Schedule A One-To-One Meeting with Our Experts At ASCO 2023 from June 2-6, 2023.

Join us simply by filling up the form upright.

Oncology Conference Coverage Services

DelveInsight’s Oncology Conference Coverage Services provided a detailed analysis of conference coverage outcomes of various conferences, including ASCO 2022, ESMO, ASH, AACR, ASTRO, SOHO, SITC, European CAR T-cell Meeting, IASLC 2023, leading to effective competitive intelligence assessment and anticipation of market trends to develop future road maps.

Oncology Portfolio Management

DelveInsight's Oncology Portfolio Management services are unrivaled in understanding skills in the cancer domain. Furthermore, we prioritize strategic goals, analyze developments in the oncology segment, understand the current needs of the oncology market, and seek to provide value for client services.

Rare Diseases Analysis

DelveInsight intends to provide useful reports that are relevant to the rare cancer market. Our analysts monitor competing products’ developmental, regulatory, and commercial milestones. It comprises features such as conference evaluation and company and R&D development evaluation to carry out the desired development of an oncological product for commercial purposes dealing with the client’s area of interest.

Consulting Services

Our multidimensional, purposeful, and credible consultancy services will aid in the acceleration of oncology product services, including aspects such as congress intelligence, conference coverage, CI asset/indication tracking, brand presence and penetration assessment, drug therapy uptake, and diagnostic landscape assessment to overcome several oncology market challenges.

Competitive Intelligence

We stand out from the crowd by hiring a specialized primary Competitive Intelligence research team. It constitutes analysts, senior analysts, and managers. Our CI force provides the finest opportunity and most accurate intelligence to be obtained and shared with our allies. Furthermore, extraordinary data collecting with the primary purpose of acquiring best-in-class intelligence and offering analysis in relation to our partners’ consulting goals.

R&D Analysis

Our research and development analyst understands the oncology domain to make value-based judgments and assist clients in achieving superior oncological R&D outcomes. The path of each oncological medicine through pre-clinical and clinical development is completed by evaluating the same factors as other candidates currently in the field. Similar is done for the oncology drugs as well. DelveInsight’s insightful oncological reports clarify uncertainties and challenge blind spots to provide the organization with timely intelligence.

Pipeline Assessment

DelveInsight's Oncological Pipeline Assessment promises a comprehensive picture of cancer therapies, clinical trials, and highlights of the cancer therapeutics landscape in a report format. Our Pipeline Assessment report type, which includes oncology-ready reports already available in our Report Store, gives insights across treatments, MoAs, Drugs, APIs, and Launch Insights of therapies in late-stage development to provide awareness of their launch timelines and strategies.

We welcome you to discuss your business-related concerns, and we can together find the best possible solution to help you proceed further in the oncological market.

    Rajesh Kumar

    Rajesh is an extremely enthusiastic and dedicated professional who is self-motivated, hard-working, and having decision-making ability. With more than 10+ years of experience in market research having expertise in Market intelligence, BD&L, Strategic Planning, and Forecasting. Throughout these years, his major focus was Oncology and Rare Diseases space.

The ASCO 2023 conference and exhibition will take place at McCormick Place, Chicago, IL, from June 2-6, 2023.

Counting Down
02 – 06 June 2023

Get in Touch with Us